Miami (October 13, 2026) – The Bronchiectasis and NTM Association announced today that an abstract using Bronchiectasis and NTM Research Registry data will be presented as a rapid-fire presentation at CHEST 2026, held October 18-21, 2026, in Phoenix.
The abstract, “Bronchiectasis in Sjögren’s Syndrome: Data from the U.S. Bronchiectasis and NTM Research Registry,” compared the demographic, clinical, and microbiologic characteristics of people with Sjögren’s syndrome-associated bronchiectasis to people with bronchiectasis without Sjögren’s syndrome.
The Registry, an initiative of the Bronchiectasis and NTM Association, is a national database that collects clinical data from individuals diagnosed with non-cystic fibrosis (non-CF) bronchiectasis and nontuberculous mycobacterial (NTM) pulmonary disease. It includes participants from multiple clinical institutions across the United States to help support collaborative research and planning of multi-center clinical trials.
The Bronchiectasis and NTM Association would like to acknowledge that the Registry is supported in part by corporate donors, all of which can be found on the Supporters page of the Association website.
For more information about the Bronchiectasis and NTM Research Registry, visit www.bronchandntm.org .
###
About Bronchiectasis and NTM Lung Disease
Bronchiectasis is a chronic lung disease characterized by enlarged airways that are thickened and/or scarred. These permanently widened airways lead to a buildup of mucus and impaired clearance of bacteria from the lungs. Between 340,000 and 522,000 adults are receiving treatment in the U.S.
Nontuberculous mycobacterial (NTM) pulmonary disease is a chronic respiratory condition caused by certain types of mycobacteria commonly found in the environment, such as in soil and water. NTM pulmonary disease predominantly affects individuals with compromised immune systems or pre-existing lung conditions, such as bronchiectasis and chronic obstructive pulmonary disease (COPD). NTM lung disease affects tens of thousands of individuals in the U.S. with rates of infection on the rise.
About the Bronchiectasis and NTM Association
The Bronchiectasis and NTM Association is a nonprofit organization whose mission is to improve the lives of people with bronchiectasis, nontuberculous mycobacterial lung (NTM) disease, or both conditions. The Association accomplishes this by providing education, supporting advocacy, furthering research, and advancing high-quality, specialized care. For more information, visit www.bronchandntm.org .